4//SEC Filing
McRae Robert Curtis 4
Accession 0001493152-23-011082
CIK 0001357459other
Filed
Apr 4, 8:00 PM ET
Accepted
Apr 5, 6:52 PM ET
Size
9.4 KB
Accession
0001493152-23-011082
Insider Transaction Report
Form 4
McRae Robert Curtis
Chief Operating Officer
Transactions
- Exercise/Conversion
Restricted Stock Units
2023-04-03−655→ 1,963 total→ Common Stock (655 underlying) - Exercise/Conversion
Common Stock, par value $0.01
2023-04-03+655→ 895 total - Tax Payment
Common Stock, par value $0.01
2023-04-03$2.00/sh−270$540→ 625 total
Footnotes (3)
- [F1]Each restricted stock unit represents the right to receive, at settlement, one share of common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date.
- [F2]Represents shares withheld by Issuer to satisfy tax withholding requirements on vesting of restricted stock units.
- [F3]This restricted stock unit was granted on January 3, 2023, and 655 restricted stock units subject to the award vested on April 3, 2023, and approximately 654 restricted stock units are scheduled to vest on each of July 3, 2023, October 3, 2023, and January 3, 2023, subject to Reporting Person continuing to be a service provider to Issuer at the time of vesting.
Documents
Issuer
PALISADE BIO, INC.
CIK 0001357459
Entity typeother
Related Parties
1- filerCIK 0001965845
Filing Metadata
- Form type
- 4
- Filed
- Apr 4, 8:00 PM ET
- Accepted
- Apr 5, 6:52 PM ET
- Size
- 9.4 KB